Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Minimal Residual Disease Detection

Peter Gibbs

MBBS, MD, FRACP

🏢Walter and Eliza Hall Institute of Medical Research🌐Australia

Professor of Medical Oncology

60
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Peter Gibbs co-leads the DYNAMIC clinical trial program that has generated landmark evidence for ctDNA-guided adjuvant therapy in colorectal cancer, demonstrating that MRD-negative patients can safely forgo chemotherapy. His extensive clinical trial network across Australia and internationally has enabled rapid enrollment and validation of MRD-guided strategies in gastrointestinal cancers. He continues to expand the DYNAMIC platform to additional cancer types and treatment settings.

Share:

🧪Research Fields 研究领域

DYNAMIC trial co-leadership
GI cancer MRD
ctDNA adjuvant guidance
Colorectal cancer surveillance
Translational clinical trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Peter Gibbs 的研究动态

Follow Peter Gibbs's research updates

留下邮箱,当我们发布与 Peter Gibbs(Walter and Eliza Hall Institute of Medical Research)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment